ARRB1 and lung cancer: The significant increase of plasma concentrations of beta-arrestin-1 specific to lung cancer samples is a promising novel finding that warrants further efforts to validate beta-arrestin-1 measurement in plasma as a powerful tool for non-invasive lung cancer diagnosis.